HOME Top Market Reports Flow Cytometry Market by Technology (Cell & Bead-based), Products & Services (Reagents, Instruments, Software, & Accessories), Application (Research & Clinical), End User (Commercial Organizations & Diagnostics Laboratories) - Global Forecasts to 2018

Flow Cytometry Market by Technology (Cell & Bead-based), Products & Services (Reagents, Instruments, Software, & Accessories), Application (Research & Clinical), End User (Commercial Organizations & Diagnostics Laboratories) - Global Forecasts to 2018

By: marketsandmarkets.com
Publishing Date: April 2014
Report Code: MD 2408

 

Enquiry Before Buying
 
purchase report
download pdf  request for customisation


On the basis of the type of technology, the flow cytometry market is segmented into cell-based, bead-based, and others. The cell-based flow cytometry segment accounted for the largest share of the global market in 2013. This is mainly because cell-based assays encompass the benefits of testing the compounds activity against molecular targets within the context of living cells; thus it is increasingly used in drug discovery processes. However, bead based flow cytometry is expected to grow at a higher rate as compared to the cell based ones because of decreased system cost, better statistical performance, and enhanced hybridization kinetics.

Furthermore, on the basis of products and services, the global flow cytometry market has been segmented into instruments, reagents and consumables, software, services, and accessories. The reagents and consumables segment accounted for the largest share in 2013 of the global flow cytometry products and services market, primarily because of the factors such as launch of new reagents for specific applications and growing focus of global players to augment their reagents and consumables offerings.

On the basis of the type of applications, the global market is classified into three categories, namely, research fields, clinical applications, and industrial applications. Research fields commands the major chunk of the global market in 2013; while, the clinical application is the fastest growing segment in this market. On the basis of the end users, the global flow cytometry market has been segmented into commercial organizations, hospitals, academic institutes, medical schools, and clinical testing labs. Commercial organization commanded the major chunk of the global market in 2013 and is the fastest growing segment along with clinical testing labs in this market.

Increasing applications of technological advancements in flow cytometry instruments, fostering research activities in the field of life sciences, growing clinical trials, fostering prevalence of HIV and cancer, launch of new reagents for specific applications such as diagnostics, drug discovery, and the development of user friendly and intuitive software’s are driving the growth of the market. However, a number of factors including high cost of instruments, reluctance among researchers to use flow cytometers (due to complexity and consumption of large space), dearth of training, and lack of awareness among probable users are restricting the market growth. Emerging countries, development of mass cytometry, fostering stem cell research, and evolution of high throughput flow cytometry provide numerous opportunities for the market players.

Geographically, the global flow cytometry market is divided into four regions, namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America and a major part of the European region are saturated markets for this products. North America accounted for the largest share of the global market in 2013. This growth is attributed to a number of factors such as presence of flow cytometry associations in this region, increasing use of flow cytometry techniques in cancer research, rise in investment initiatives by the government, and high quality infrastructure for clinical and laboratory research. The emerging markets including China and India are becoming attractive for the companies engaged in the development and marketing of the products. Various economic developments and growing prevalence of HIV/AIDS, growing number of research initiatives, increasing government support, and growing focus of both international and domestic players are the key factors propelling the demand for flow cytometry products in the Asia-Pacific region.

As of 2013, Becton, Dikinson and Company (U.S.) holds the leadership position in this market globally. Over the past three years, the company adopted new product launches, collaborations, and strategic acquisitions as its key business strategies to ensure its dominant position in this market. Some of the key players in this market are Becton, Dickinson and Company, Beckman Coulter, Inc. (U.S.), e Biosciences, Inc. (U.S.), EMD Millipore Corporation (U.S.), Life Technologies Corporation (U.S.), Luminex Corporation (U.S.), Miltenyi Biotec (Germany), and Partec GmbH (Germany), are some of the other key players in this market.

Scope of the report

This research report categorizes the global flow cytometry market into the following segments and sub-segments:

Global Flow Cytometry Market, By Technology

  • Cell-based Flow Cytometry
  • Bead-based Flow Cytometry
  • Others

Global Flow Cytometry Market, By Products

  • Instruments
  • Reagents and Consumables
  • Software
  • Services
  • Accessories

Global Flow Cytometry Market, By Applications

  • Research Fields
    • Pharmaceutical Applications
      • Drug Discovery
      • Stem Cells Research
      • In Vitro Toxicity Testing
    • Apoptosis
    • Cell Cycle Analysis
    • Cell Sorting
    • Cell Viability
    • Immunology
    • Others
  • Clinical Applications
    • Organ Transplantation
    • Cancer
    • Immunodeficiency Diseases
    • Hematology
    • Others
  • Industrial Applications

Global Flow Cytometry Market, By End Users

  • Commercial Organizations
  • Hospitals
  • Academic Institutes
  • Medical Schools
  • Clinical Testing Labs

Table Of Contents
 
1 Introduction (Page No. - 17)
    1.1 Objectives of The Study
    1.2 Report Description
    1.3 Markets Covered
    1.4 Stakeholders
    1.5 Market Scope
    1.6 Research Methodology
          1.6.1 Market Size Estimation
          1.6.2 Market Breakdown & Data Triangulation
          1.6.3 Market Share Estimation
          1.6.4 Key Data Points Taken From Secondary Sources
          1.6.5 Key Data Points Taken From Primary Sources
          1.6.6 Assumptions

2 Executive Summary (Page No. - 30)

3 Premium Insights (Page No. - 37)
    3.1 Flow Cytometry Market, By Geography
    3.2 Flow Cytometry Market, By Segments
    3.3 Flow Cytometry Market, By Applications
    3.4 Competitive Analysis

4 Market Overview (Page No. - 42)
    4.1 Introduction
    4.2 Evolution
    4.3 Market Segmentation
          4.3.1 Flow Cytometry Market, By Technology
          4.3.2 Flow Cytometry Market, By Products & Services
          4.3.3 Flow Cytometry Market, By End-Users
          4.3.4 Flow Cytometry Market, By Application
    4.4 Market Dynamics
          4.4.1 Market Drivers
                   4.4.1.1 Technological Advancements in Flow Cytometry Instruments
                   4.4.1.2 Fostering Use of Flow Cytometry Techniques in Research Activities
                   4.4.1.3 Increasing Use of Flow Cytometry in Clinical Trials
                   4.4.1.4 Increasing Use of Flow Cytometry in Hiv and Cancer Research
                   4.4.1.5 Launch of New Reagents For Specific Applications Like Diagnostics and Drug Discovery.
                   4.4.1.6 Development of User-Friendly and Intuitive Software
          4.4.2 Restraints
                   4.4.2.1 High Cost of Instruments
                   4.4.2.2 Reluctance Among Researchers to Use Flow Cytometer in Emerging Countries
                   4.4.2.3 Lack of Awareness and Dearth of Training
          4.4.3 Challenges
                   4.4.3.1 Lack of Proper Infrastructure For Conducting Research Activities in Emerging Countries
                   4.4.3.2 Complexity Related to Reagent Development
          4.4.4 Opportunities
                   4.4.4.1 Emerging Markets
                   4.4.4.2 Development of Mass Cytometry and Combination of Cell- and Bead-Based Flow Cytometry Technologies
                   4.4.4.3 Fostering Stem Cell Research
                   4.4.4.4 Evolution of High Throughput Flow Cytometry

5 Industry Trends (Page No. - 59)
    5.1 Introduction
    5.2 Supply Chain Analysis
    5.3 Industry Trends
          5.3.1 Development of Multicolor Flow Cytometry
          5.3.2 The Push For Technology Adoption
          5.3.3 Embracement of Basic Flow-Cytometry Techniques in Modern Hematology Analyzers
    5.4 Burning Issues
    5.5 Regulatory Challenges
          5.5.1 Challenging Food and Drug Administration (FDA) Requirements
          5.5.2 Stringent Analyte Specific Reagent (ASR) Rule
          5.5.3 Cell Based Validation Challenges
          5.5.4 Dearth of Laboratory-Developed Tests (LDT) Guidelines on Cell-Based Fluorescence Assays
          5.5.5 Changing Regulatory Enviornment
    5.6 Reimbursement Isssues
    5.7 Winning Imperatives
          5.7.1 Strategy of Diversification of Product Portfolio
          5.7.2 Strategy of Geographic Expansion in Emerging Markets
          5.7.3 Strategy For The Development of Specific Reagents
    5.8 Porter’s Five Forces Analysis
          5.8.1 Threat From New Entrants
          5.8.2 Threat From Substitutes
          5.8.3 Bargaining Power of Suppliers
          5.8.4 Bargaining Power of Buyers
          5.8.5 Intensity of Competitive Rivalry

6  By Technology (Page No. - 76)
    6.1 Introduction
    6.2 Cell Based Flow Cytometry
    6.3 Bead Based Flow Cytometry
    6.4 Others

7 By Products and Services (Page No. - 84)
    7.1 Introduction
    7.2 Flow Cytometry Instruments
    7.3 Reagents and Consumables
    7.4 Software
    7.5 Accessories
    7.6 Services

8 By Application (Page No. - 95)
    8.1 Introduction
    8.2 Research Field
          8.2.1 Pharmaceutical Applications
                   8.2.1.1 Drug Discovery
                   8.2.1.2 Stem Cells Research
                   8.2.1.3 In-Vitro toxicity Testing
          8.2.2 Apoptosis
          8.2.3 Cell Cycle Analysis
          8.2.4 Cell Sorting
          8.2.5 Cell Viability
          8.2.6 Immunology
          8.2.7 Others
    8.3 Clinical Applications
          8.3.1 Organ Transplantation
          8.3.2 Cancer
          8.3.3 Immunodeficiency Diseases
          8.3.4 Hematology
          8.3.5 Others
    8.4 Industrial Applications

9 By End Users (Page No. - 126)
    9.1 Introduction
    9.2 Commercial Organizations
    9.3 Hospitals
    9.4 Acedemic Institutes
    9.5 Medical Schools
    9.6 Clinical Testing Labs

10 By Geography (Page No. - 138)
    10.1 Introduction
    10.2 North America
          10.2.1 U.S.
          10.2.2 Canada
    10.3 Europe
          10.3.1 U.K.
          10.3.2 Germany
          10.3.3 France
          10.3.4 Rest of Europe
    10.4 Asia-Pacific
          10.4.1 Japan
          10.4.2 China
          10.4.3 India
          10.4.4 Rest of Asia-Pacific
    10.5 Rest of The World (ROW)

11 Competitive Landscape (Page No. - 181)
    11.1 Overview
    11.2 Market Share Analysis, By Key Players
    11.3 Competitive Situation and Trends
          11.3.1 New Product Launches
          11.3.2 Agreements, Partnerships, Collaborations, & Joint Ventures
          11.3.3 Mergers and Acquisitions
          11.3.4 Expansions
          11.3.5 Other Developments

12 Company Profile (Page No. - 206)
    12.1 Becton, Dickinson and Company
          12.1.1 Business Overview
          12.1.2 Products & Services
          12.1.3 Key Strategy
          12.1.4 Recent Developments
          12.1.5 SWOT
          12.1.6 MNM View
    12.2 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
          12.2.1 Business Overview
          12.2.2 Products & Services
          12.2.3 Key Strategy
          12.2.4 Recent Developments
          12.2.5 SWOT
          12.2.6 MNM View
    12.3 Ebioscience, Inc. (A Subsidiary of Affymetrix, Inc.)
          12.3.1 Business Overview
          12.3.2 Products & Services
          12.3.3 Key Strategy
          12.3.4 Recent Developments
          12.3.5 SWOT
          12.3.6 MNM View
    12.4 Emd Millipore Corporation (A Division of Merck Kgaa)
          12.4.1 Business Overview
          12.4.2 Products & Services
          12.4.3 Key Strategy
          12.4.4 Recent Developments
          12.4.5 SWOT
          12.4.6 MNM View
    12.5 Life Technologies Corporation (A Brand of Thermo Fisher Scientific, Inc.)
          12.5.1 Business Overview
          12.5.2 Products & Services
          12.5.3 Key Strategy
          12.5.4 Recent Developments
          12.5.5 SWOT
          12.5.6 MNM View
    12.6 Bio-Rad Laboratories, Inc.
          12.6.1 Business Overview
          12.6.2 Products & Services
          12.6.3 Key Strategy
          12.6.4 Recent Developments
    12.7 Luminex Corporation
          12.7.1 Business Overview
          12.7.2 Products & Services
          12.7.3 Key Strategy
          12.7.4 Recent Developments
    12.8 Miltenyi Biotech
          12.8.1 Business Overview
          12.8.2 Products & Services
          12.8.3 Key Strategy
          12.8.4 Recent Developments
    12.9 Partec GMBH
          12.9.1 Business Overview
          12.9.2 Products & Services
          12.9.3 Key Strategy
          12.9.4 Recent Developments
    12.10 TTP Labtech LTD.
          12.10.1 Business Overview
          12.10.2 Products & Services
          12.10.3 Key Strategy
          12.10.4 Recent Developments


List of Tables (103 Tables)

Table 1 Global Flow Cytometry Market Size, By Technology, 2011—2018 ($Million)
Table 2 Global Market Size, By Product and Services, 2011—2018 ($Million)
Table 3 Global Market Size, By Application, 2011—2018 ($Million)
Table 4 Global Market Size, By End-User, 2011—2018 ($Million)
Table 5 Flow Cytometry Technology Market Size, By Geography, 2011—2018 ($Million)
Table 6 Global Market, By Technology, 2011 – 2018 ($Million)
Table 7 Flow Cytometry Technology Market, By Geography, 2011 – 2018 ($Million)
Table 8 Cell-Based Flow Cytometry Market, By Geography, 2011–2018 ($Million)
Table 9 Bead-Based Flow Cytometry Market, By Geography, 2011 – 2018 ($Million)
Table 10 Other Flow Cytometry Technology Market, By Geography, 2011 – 2018 ($Million)
Table 11 Global Market, By Products, 2011 – 2018 ($Million)
Table 12 Flow Cytometry Instruments Market,By Geography, 2011–2018 ($Million)
Table 13 Flow Cytometry Reagents and Consumables Market, By Geography, 2011–2018 ($Million)
Table 14 Flow Cytometry Software Market, By Geography, 2011 – 2018 ($Million)
Table 15 Flow Cytometry Accessories Market,By Geography, 2011 – 2018 ($Million)
Table 16 Flow Cytometry Services Market,By Geography, 2011 – 2018 ($Million)
Table 17 Global Market, By Applications, 2011 – 2018 ($Million)
Table 18 Global Market in Research, 2011–2018 ($Million)
Table 19 Global Flow Cytometry Market in Pharmaceutical Research, 2011–2018 ($Million)
Table 20 Flow Cytometry Market in Drug Discovery, By Geography, 2011–2018 ($Million)
Table 21 Market in stem Cells Research, By Geography, 2011 – 2018 ($Million)
Table 22 Market in in-Vitro toxicity Testing, By Geography, 2011–2018 ($Million)
Table 23 Market in Apoptosis, By Geography, 2011–2018 ($Million)
Table 24 Market in Cell Cycle Analysis, By Geography 2011–2018 ($Million)
Table 25 Market in Cell Sorting, By Geography, 2011–2018 ($Million)
Table 26 Market in Cell Viability, By Geography, 2011–2018 ($Million)
Table 27 Market in Immunology, By Geography, 2011–2018 ($Million)
Table 28 Market in Other Research, By Geography, 2011–2018 ($Million)
Table 29 Global Flow Cytometry Market in Clinical Applications, 2011–2018 ($Million)
Table 30 Market in Organ Transplantation, By Geography, 2011–2018 ($Million)
Table 31 Market in Cancer, By Geography, 2011–2018 ($Million)
Table 32 Market in Immunodeficiency Diseases, By Geography, 2011 – 2018 ($Million)
Table 33 Market in Hematology, By Geography, 2011–2018 ($Million)
Table 34 Market in Other Clinical Applications, By Geography, 2011–2018 ($Million)
Table 35 Market in Industrial Applications,2011 – 2018 ($Million)
Table 36 Global Flow Cytometry Market, By End Users 2011 – 2018 ($Million)
Table 37 Market in Commercial Organizations, By Geography 2011 – 2018 ($Million)
Table 38 Market in Hospitals, By Geography 2011–2018 ($Million)
Table 39 Market in Academic Institutions, By Geography 2011–2018 ($Million)
Table 40 Market in Medical Schools, By Geography 2011–2018 ($Million)
Table 41 Market in Clinical Testing Labs, By Geography 2011–2018 ($Million)
Table 42 Flow Cytometry Market, By Geography, 2011 – 2018 ($Million)
Table 43 North America: Flow Cytometry Market, By Technology 2011 – 2018 ($Million)
Table 44 North America: Market, By Products & Services 2011 – 2018 ($Million)
Table 45 North America: Market By End Users,2011–2018 ($Million)
Table 46 North America: Market, By Application 2011–2018 ($Million)
Table 47 U.S.: Market, By Technology 2011 – 2018 ($Million)
Table 48 U.S.: Market, By Products & Services 2011 – 2018 ($Million)
Table 49 U.S.: Market By End Users 2011–2018 ($Million)
Table 50 U.S.: Market, By Application 2011–2018 ($Million)
Table 51 Canada: Market, By Technology 2011–2018 ($Million)
Table 52 Canada: Market, By Products & Services 2011–2018 ($Million)
Table 53 Canada: Market, By End Users, 2011–2018 ($Million)
Table 54 Canada: Market, By Application, 2011–2018 ($Million)
Table 55 Europe: Flow Cytometry Market, By Technology, 2011–2018 ($Million)
Table 56 Europe: Market, By Products & Services 2011–2018 ($Million)
Table 57 Europe: Market, By End Users, 2011–2018 ($Million)
Table 58 Europe: Market, By Application, 2011 – 2018 ($Million)
Table 59 U.K.: Market, By Technology 2011 – 2018 ($Million)
Table 60 U.K.: Market, By Products & Services 2011 – 2018 ($Million)
Table 61 U.K.: Market By End Users 2011–2018 ($Million)
Table 62 U.K.: Market, By Application 2011–2018 ($Million)
Table 63 Germany: Market, By Technology, 2011–2018 ($Million)
Table 64 Germany: Market, By Products & Services 2011–2018 ($Million)
Table 65 Germany: Market, By End Users, 2011–2018 ($Million)
Table 66 Germany: Market, By Application, 2011 – 2018 ($Million)
Table 67 France: Market, By Technology, 2011–2018 ($Million)
Table 68 France: Market, By Products & Services 2011–2018 ($Million)
Table 69 France: Market, By End Users, 2011–2018 ($Million)
Table 70 France: Market, By Application, 2011–2018 ($Million)
Table 71 ROE: Market, By Technology 2011–2018 ($Million)
Table 72 ROE: Market, By Products & Services 2011–2018 ($Million)
Table 73 ROE: Market, By End Users, 2011–2018 ($Million)
Table 74 ROE: Market, By Application, 2011–2018 ($Million)
Table 75 Asia-Pacific: Market, By Technology,2011–2018 ($Million)
Table 76 Asia-Pacific: Market, By Products & Services 2011–2018 ($Million)
Table 77 Asia-Pacific: Market, By End Users, 2011–2018 ($Million)
Table 78 Asia-Pacific: Market, By Application, 2011–2018 ($Million)
Table 79 Japan: Flow Cytometry Market, By Technology, 2011–2018 ($Million)
Table 80 Japan: Market, By Products & Services 2011–2018 ($Million)
Table 81 Japan: Market, By End Users, 2011–2018 ($Million)
Table 82 Japan: Market, By Application, 2011 – 2018 ($Million)
Table 83 China: Flow Cytometry Market, By Technology, 2011–2018 ($Million)
Table 84 China: Market, By Products & Services 2011–2018 ($Million)
Table 85 China: Market, By End Users, 2011–2018 ($Million)
Table 86 China: Market, By Application, 2011–2018 ($Million)
Table 87 India: Market, By Technology 2011 – 2018 ($Million)
Table 88 India: Market, By Products & Services 2011 – 2018 ($Million)
Table 89 India: Market By End Users 2011–2018 ($Million)
Table 90 India: Market, By Application 2011–2018 ($Million)
Table 91 ROAPAC: Flow Cytometry Flow Cytometry Market, By Technology 2011–2018($Million)
Table 92 ROAPAC: Market, By Products & Services 2011–2018 ($Million)
Table 93 ROAPAC: Market, By End Users, 2011–2018 ($Million)
Table 94 ROAPAC: Market, By Application, 2011–2018 ($Million)
Table 95 ROW: Flow Cytometry Market, By Technology, 2011–2018 ($Million)
Table 96 ROW: Market, By Products & Services 2011–2018 ($Million)
Table 97 ROW: Market, By End Users, 2011–2018 ($Million)
Table 98 ROW: Market, By Application, 2011–2018 ($Million)
Table 99 New Product Launches, 2011–2014
Table 100 Agreements, Partnerships, Collaborations, and Joint Ventures, 2011–2014
Table 101 Mergers and Acquisitions, 2011–2014
Table 102 Expansion, 2011–2014
Table 103 Other Developments, 2011 – 2014


List of Figures (16 Figures)

Figure 1 Research Methodology
Figure 2 Market Size Estimation Methodology
Figure 3 Flow Cytometry Technology Market Share, By Geography
Figure 4 Global Market, By Geography, 2013 & 2018 ($Million)
Figure 5 Market, By Segments, 2013 & 2018 ($Million)
Figure 6 Market, By Applications, 2013
Figure 7 Geographic Reach Vs Product Portfolio, By Key Players, 2013
Figure 8 Evolution
Figure 9 Flow Cytometry Market, By Technology
Figure 10 Market, By Products & Services
Figure 11 Market, By End-Users
Figure 12 Market, By Application
Figure 13 Market: Supply Chain
Figure 14 Porter’s Five Forces Analysis: Global Market, 2013
Figure 15 Global Market Share, By Key Players, 2012
Figure 16 Key Growth Strategies, 2011–2014

On the basis of products, the global flow cytometry market has been segmented into instruments, reagents and consumables, software, services, and accessories. In 2013, the reagents and consumables segment accounted for the largest share of 45%in the global market, and is also expected to grow at the highest CAGR of 11.2% from 2013 to 2018. In addition, the global market is classified into three segments based on the type of technology, namely, cell-based, bead-based, and others. The cell-based segment accounted for the largest share of 80% in the global market

In the report, the global market is further segmented on the basis of type of end users, which includes commercial organizations, hospitals, academic institutions, medical schools, and clinical testing labs. In 2013, the commercial organization segment accounted for the largest share of 35% in the market. Likewise, based on the type of applications, the global market is classified into three categories, namely, research, clinical, and industrial applications. Application of flow cytometry in the research fields commands the major chunk of the market in 2013.

The global flow cytometry market is expected to reach $3.7 billion by 2018, at a CAGR of 10% from 2013 to 2018.

Increasing applications of technological advancements in flow cytometry instruments, fostering research activities in the field of life sciences, growing clinical trials, fostering prevalence of HIV and cancer, launch of new reagents for specific applications such as diagnostics, drug discovery and development of user friendly and intuitive software’s are driving the growth of the flowcytometry market. Additionally, emerging markets such as China and India, development of high throughput flow cytometry, and fostering stem cells research unfolds new opportunities for the market players.

However, a number of factors including high cost of instruments, reluctance among researchers to use flow cytometers (due to complexity and consumption of large space), dearth of training, and lack of awareness among probable users are restricting the market growth. Furthermore, lack of adequate infrastructural developments in the emerging countries, and complexity related to reagent developments poses as key challenges to the growth of market.

The global flow cytometry market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America will continue to dominate the market in the forecast period (2013-2018). However, the Asia-Pacific region is expected to grow at the highest CAGR of 16% from 2013 to 2018. Over the next five years, the growth of the market in the Asia-Pacific region is likely to be centered at Japan, China, and India. A number of factors such as various economic developments and growing prevalence to HIV/AIDS, growing number of research initiatives, increasing government support, growing awareness, and growing focus of both international and domestic players are driving the growth of the market in the Asia-Pacific region.

New product launches is the key strategy followed by the leading market players to ensure their growth in the market. Moreover, partnerships, agreements, collaborations and joint ventures, mergers and acquisitions, and expansions are some other growth strategies adopted by the industry players in the global market.

The flow cytometry market is a diversified and competitive market. The key players in this market are Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), eBioscience, Inc. (U.S.), EMD Millipore Corporation (U.S.), Life Technologies Corporation (U.S.), Luminex Corporation (U.S.), Miltenyi Biotec (Germany), and Partec GmbH (Germany).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports